List of works by Laurence Zitvogel

A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1.

scientific article published on 24 July 2015

A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers

scientific article published on 26 April 2019

A novel dendritic cell subset involved in tumor immunosurveillance

scientific article published on 29 January 2006

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

scientific article published on 07 September 2019

A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment.

scientific article published on 11 December 2017

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy

scientific article published on 16 April 2013

Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy

scientific article published on July 2012

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

scientific article (publication date: October 2009)

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

scientific article published on 8 May 2011

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells

scientific article published on January 2013

An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy

scientific article published on 3 July 2014

An immunosurveillance mechanism controls cancer cell ploidy

scientific article

An inhibitor of cyclin-dependent kinases suppresses TLR signaling and increases the susceptibility of cancer patients to herpesviridae.

scientific article published in January 2011

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort

scientific article published on March 2013

Antibiotics impair immunotherapy for urothelial cancer

scientific article published on 08 September 2020

Antibody co-targeting of DCs

scientific article published on 01 December 2011

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

scientific article

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

scientific article published on 4 April 2013

Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors.

scientific article published on 4 November 2015

Anticancer effects of anti-CD47 immunotherapy in vivo

scientific article published on 11 December 2018

Anticancer effects of imatinib via immunostimulation

scientific article published on 07 September 2011

Anticancer effects of the microbiome and its products

scientific article published on 22 May 2017

Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects

scientific article published on 20 July 2009

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

scientific article published on 5 November 2015

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Antigen presentation and T cell stimulation by dendritic cells

scientific article

Apoptosis regulation in tetraploid cancer cells

scientific article

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

scientific article published on 17 April 2019

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

scientific article

Autophagy and cellular immune responses

scientific article published on August 2013

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

scientific article (publication date: 16 December 2011)

BCR/ABL promotes dendritic cell-mediated natural killer cell activation

scientific article published in July 2005

Bacterial invasion: linking autophagy and innate immunity

scientific article published on 01 February 2010

Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate

scientific article

CANCER. A p53-regulated immune checkpoint relevant to cancer

scientific article published on 01 July 2015

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy

scientific article published on 3 December 2013

CD103+ dendritic cells producing interleukin-12 in anticancer immunosurveillance

scientific article published on 10 November 2014

CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes

scientific article published on 04 December 2018

CD4+ T Cells at the Center of Inflammaging

scientific article published on 25 April 2020

CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer

scientific article published on October 2008

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

scientific article

COVID-19: a challenge for oncology services

scientific article published on 05 May 2020

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

scientific article published on July 2016

Calreticulin exposure dictates the immunogenicity of cancer cell death

scientific article

Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia

scientific article

Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer

scientific article published on 09 June 2016

Can the exome and the immunome converge on the design of efficient cancer vaccines?

scientific article

Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?

scientific article published on 13 July 2020

Cancer and the gut microbiota: an unexpected link

scientific article published on January 2015

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

scientific article

Cancer despite immunosurveillance: immunoselection and immunosubversion

scientific article

Cancer immunotherapy in 2017: The breakthrough of the microbiota

scientific article

Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts ⬇️

scientific article published on 01 August 1995

Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells

scientific article published on 16 March 2012

Cancer: Antibodies regulate antitumour immunity.

scientific article

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

scientific article

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

scientific article

Cell-death-associated molecular patterns as determinants of cancer immunogenicity

scientific article published on 20 March 2013

Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients

scientific article published on 28 July 2015

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

scientific article published on 01 March 2006

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

scientific article

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy

scientific article published on 10 January 2014

Chemotherapy and radiotherapy: cryptic anticancer vaccines

scientific article published on 18 April 2010

Chemotherapy induces ATP release from tumor cells

scientific article published on 8 November 2009

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

scientific article published on 29 October 2015

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

scientific article published on 25 May 2020

Classification of current anticancer immunotherapies

scientific article

Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade

scientific article published on 22 July 2019

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

scientific article

Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?

scientific article published on 5 June 2015

Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses

scientific article published on 08 July 2020

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

scientific article published on October 2015

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer

scientific article published on 14 November 2019

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer

scientific article

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

scientific article published on 01 March 2020

Consensus guidelines for the detection of immunogenic cell death

scientific article published on October 2014

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

scientific article

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

scientific article published on 10 March 2016

Contribution of annexin A1 to anticancer immunosurveillance

scientific article published on 14 August 2019

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines

scientific article published on 07 June 2013

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

scientific article published on 02 April 2019

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

scientific article published on 28 February 2022

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

scientific article published on 01 August 2020

Crosstalk between ER stress and immunogenic cell death

scientific article published on 17 June 2013

Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?

scientific article published in August 2008

Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.

scientific article published on 12 November 2012

Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria.

scientific article published on 17 December 2010

Cyclophosphamide induces differentiation of Th17 cells in cancer patients

scientific article published on 09 December 2010

Cytokines reinstate NK cell-mediated cancer immunosurveillance

scientific article

Death, danger, and immunity: an infernal trio

scientific article published on 01 December 2007

Decoding cell death signals in inflammation and immunity

scientific article published on 01 March 2010

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

scientific article published on 28 June 2013

Defining the critical hurdles in cancer immunotherapy

scientific article published on 14 December 2011

Dendritic and natural killer cells cooperate in the control/switch of innate immunity

scientific article

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation

scientific article published on 05 August 2008

Dendritic cell derived-exosomes: biology and clinical implementations

scientific article published on 29 June 2006

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production

scientific article

Dendritic cell-NK cell cross-talk: regulation and physiopathology.

scientific article

Dendritic cell-based immunotherapy of cancer

scientific article

Dendritic cell-derived exosomes as cell-free peptide-based vaccines

scientific article

Dendritic cell-derived exosomes as immunotherapies in the fight against cancer

scientific article

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

scientific article published on 12 August 2015

Dendritic cell-derived exosomes for cancer immunotherapy: what's next?

scientific article published on 09 February 2010

Dendritic cell-derived exosomes for cancer therapy

scientific article published on April 2016

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha

scientific article

Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk.

scientific article

Dendritic cells and innate defense against tumor cells

scientific article published on 26 December 2007

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients

scientific article published on 18 September 2002

Desirable cell death during anticancer chemotherapy

scientific article published on October 2010

Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis

scientific article published on 11 September 2015

Disruption of the PP1/GADD34 complex induces calreticulin exposure

scientific article published on 28 December 2009

Ecto-calreticulin in immunogenic chemotherapy

scientific article published on December 2007

Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

scientific article published on 09 June 2021

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

scientific article published on 05 August 2020

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

scientific article published on 20 July 2020

Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota

scientific article published on 18 February 2016

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

scientific article

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article published in March 2015

Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer

scientific article published in 2022

Exosome-based immunotherapy

scientific article published on 16 January 2004

Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides

scientific article published on September 2003

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

scientific article published on February 2004

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

scientific article published on February 2004

Exosomes for cancer immunotherapy

scientific article published in January 2004

Exosomes for immunotherapy of cancer.

scientific article

Exosomes for the treatment of human malignancies

scientific article published on February 2008

Exosomes in cancer immunotherapy: preclinical data

scientific article

Exosomes: composition, biogenesis and function

scientific article (publication date: August 2002)

Extracellular vesicles: masters of intercellular communication and potential clinical interventions

scientific article published on April 2016

Failure of immunosurveillance accelerates aging

scholarly article by Maria Perez-Lanzon et al published 2019 in OncoImmunology

Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome

scientific article

Following up tumor-specific regulatory T cells in cancer patients

scientific article published on July 2013

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

scientific article

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

scientific article

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

scientific article published on 03 May 2020

Gut microbiome and anticancer immune response: really hot Sh*t!

scientific article

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

scientific article published on 2 November 2017

Gut microbiota and efficacy of cancer therapies

scientific article published on 6 July 2017

Harnessing dendritic cells in cancer

scientific article published on 03 February 2011

Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors

scientific article published on 3 January 2014

Harnessing γδ T cells in anticancer immunotherapy

scientific article published on 23 February 2012

Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting

scientific article published on 29 May 2013

Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin

scientific article

How to improve the immunogenicity of chemotherapy and radiotherapy

scientific article published on March 2011

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin

scientific article

IKDCs or B220+ NK cells are pre-mNK cells

scientific article published on 01 May 2012

IKK connects autophagy to major stress pathways

scientific article published on January 2010

IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes

scientific article published on 01 October 2005

IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules

scientific article published in May 2004

Identification of pharmacological agents that induce HMGB1 release

scientific article

Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

scientific article published on 01 December 2020

Imatinib mesylate (Gleevec): targeted therapy against cancer with immune properties

scientific article published on March 2010

Imatinib mesylate impairs Flt3L-mediated dendritic cell expansion and antitumor effects in vivo

scientific article published in March 2004

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

scientific article published on 23 May 2017

Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.

scientific article published on 7 March 2017

Immune infiltrate in cancer

scientific article published on June 2015

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

scientific article

Immune parameters affecting the efficacy of chemotherapeutic regimens

scientific article published on March 2011

Immune response against dying tumor cells

scientific article

Immune responses during COVID-19 infection

scientific article published on 25 August 2020

Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer

scientific article

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy

scientific article published on January 2014

Immunodynamics of explanted human tumors for immuno-oncology

scientific article published on 29 December 2020

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

scientific article

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

scientific article published on 09 February 2016

Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment

scientific article

Immunogenic and tolerogenic cell death

scientific article

Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.

scientific article published on 21 June 2013

Immunogenic cancer cell death: a key-lock paradigm

scientific article published on 23 June 2008

Immunogenic cell death in cancer and infectious disease

scientific article

Immunogenic cell death modalities and their impact on cancer treatment

scientific article published on April 2009

Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy

scientific article published on 31 August 2015

Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.

scientific article published on March 2007

Immunogenic death of colon cancer cells treated with oxaliplatin

scientific article published on 2 November 2009

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

scientific article published in November 2017

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway

scientific article published on 26 April 2010

Immunogenicity of anthracyclines: moving towards more personalized medicine

scientific article published on 18 March 2008

Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens

scientific article published on 31 May 2012

Immunologic correlates in the course of treatment with immunomodulating antibodies

scientific article published on 13 February 2015

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

scientific article

Immunological Mechanisms Underneath the Efficacy of Cancer Therapy

scientific article published on November 2016

Immunological aspects of cancer chemotherapy

scientific article published on January 2008

Immunological effects of chemotherapy in spontaneous breast cancers

scientific article published on 14 November 2013

Immunological off-target effects of imatinib

scientific article

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

scientific article

Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis

scientific article published on 29 January 2016

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 30 July 2020

Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice

scientific article published on 25 June 2012

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

scientific article published on 05 August 2020

Immunostimulatory gut bacteria

scientific article published on 01 November 2019

Immunosuppression by Mutated Calreticulin Released from Malignant Cells

scientific article published on 27 November 2019

Immunosurveillance as a regulator of tissue homeostasis

scientific article published on 26 July 2013

Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells

scientific article published on July 2015

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts.

scientific article

Immunotherapy and the concept of a clinical cure

scientific article

Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy

scientific article published on 16 May 2016

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts

scholarly article by Gautier Stoll et al published 2018 in OncoImmunology

Improvement of immunogenic chemotherapy by STAT3 inhibition

scientific article published on 11 September 2015

In vivo depletion of T lymphocyte-specific transcription factors by RNA interference.

scientific article published on 3 July 2010

In vivo veritas

scientific article published on 01 November 2005

Inflammasomes in carcinogenesis and anticancer immune responses

scientific article published on 18 March 2012

Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

scientific article published on 18 February 2016

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress

scientific article published on 23 April 2020

Innate or adaptive immunity? The example of natural killer cells

scientific article (publication date: 7 January 2011)

Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy

scientific article

Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).

scientific article published on 5 May 2007

Interferon-γ induces cancer cell ferroptosis

scientific article published on 01 September 2019

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

scientific article published on 07 May 2021

Introduction: the immune response against dying cells

scientific article published on 14 August 2008

Killer dendritic cells and their potential role in immunotherapy

scientific article published on February 2008

Killer dendritic cells: IKDC and the others

scientific article published on 12 June 2008

La calréticuline détermine l’immunogénicité de la chimiothérapie et de la radiothérapie antitumorales

scientific article published in March 2007

Leptin-Producing Oncolytic Virus Makes Tumor-Infiltrating T Cells Fit, Not Fat

scientific article published on 01 September 2019

Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic

scientific article published on September 2007

Links between innate and cognate tumor immunity

scientific article published on 15 February 2007

Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer

scientific article

Lung cancer: potential targets for immunotherapy

scientific article published on 23 August 2013

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer

scientific article published on 21 July 2020

Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death

scientific article

Malignant effusions and immunogenic tumour-derived exosomes

scientific article published in July 2002

Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma

scientific article published on 13 November 2013

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

scientific article published on July 2013

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

scientific article published on 22 January 2009

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells

scientific article

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies

scientific article published in May 2015

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

scientific article published on 08 September 2006

Microbiome and Anticancer Immunosurveillance

scientific article

Microbiota modulation of myeloid cells in cancer therapy

scientific article

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

scientific article

Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.

scientific article

Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy

scientific article published on March 2011

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference

scientific article published on 22 May 2007

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies

scientific article published on June 2008

Molecular mechanisms of ATP secretion during immunogenic cell death

scientific article

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

scientific article

Mouse models in oncoimmunology

scientific article

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors

scientific article

NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic

scientific article published on 12 March 2010

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome

scientific article

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

scientific article published on 8 July 2004

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

scientific article published on 25 April 2016

NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution

scientific article published on 10 March 2016

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

scientific article published on 4 January 2018

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

scientific article

Natural and therapy-induced immunosurveillance in breast cancer

scientific article published on October 2015

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients

scientific article

Natural killer cell mediated immunosurveillance of pediatric neuroblastoma

scientific article published on 5 May 2015

Natural killer cell-dendritic cell crosstalk in the initiation of immune responses

scientific article

Natural killer cell-directed therapies: moving from unexpected results to successful strategies

scientific article published on May 2008

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma

scientific article

Natural killer cells in non-hematopoietic malignancies

scientific article

Natural-killer cells and dendritic cells: "l'union fait la force".

scientific article

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer.

scientific article published on 30 March 2018

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

scientific article

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

scientific article

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

scientific article published on August 2004

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects

scientific article published in August 2004

Nutrition, inflammation and cancer

scientific article

On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2

scientific article published on 19 August 2020

OncoImmunology: a new journal at the frontier between oncology and immunology

scientific article published on January 2012

Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals

scientific article published on 23 October 2018

Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies

scientific article published on 08 October 2019

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

scientific article

Oral administration of <i>Akkermansia muciniphila</i> elevates systemic antiaging and anticancer metabolites

scientific article published on 02 March 2021

PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade

scientific article published on 09 November 2018

Pegylated Engineered IL2 plus Anti-PD-1 Monoclonal Antibody: The Nectar Comes from the Combination

scientific article published on 01 August 2020

Personalized immunotherapy: a siren myth?

scientific article published on 01 September 2009

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)

scientific article published on 22 July 2019

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate

scientific article published on February 2013

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome

scientific article published on February 2013

Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals

scientific article

Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies

scientific article published on 01 June 2020

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors

scientific article published on 6 June 2011

Positive impact of autophagy in human breast cancer cells on local immunosurveillance

scientific article published on 24 May 2016

Potent immunomodulatory effects of the trifunctional antibody catumaxomab

scientific article published on 4 June 2013

Predictors of responses to immune checkpoint blockade in advanced melanoma

scientific article published on 19 September 2017

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

scientific article published on 24 February 2012

Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy

scientific article published on September 2011

Prime time for immune-checkpoint targeted therapy at ASCO 2015

scientific article

Pro-necrotic molecules impact local immunosurveillance in human breast cancer

scientific article

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

article

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer

scientific article published on 13 May 2016

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

scientific article published on 06 July 2021

Prospects for exosomes in immunotherapy of cancer

scientific article

Proteomic analysis of exosomes secreted by human mesothelioma cells

scientific article

Pyroptosis - a cell death modality of its kind?

scientific article published on March 2010

Rationale for anti-OX40 cancer immunotherapy

scientific article

Recent successes of cancer immunotherapy: a new dimension in personalized medicine?

scientific article published on 15 February 2012

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies

scientific article published on 17 May 2020

Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering

scientific article published on 6 November 2013

Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells

scientific article published on 01 April 2008

Reply to 'Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma'

scientific article published in Nature Communications

Reply: Immunosuppressive cell death in cancer.

scientific article published on 8 May 2017

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

scientific article published on June 2016

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress

scientific article published on 13 December 2010

Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical application

scientific article published on September 1995

STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

scientific article published on 24 July 2015

STAT3 inhibition for cancer therapy: Cell-autonomous effects only?

scientific article published on 8 January 2016

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set

scientific article

Seeking Cellular Fitness and Immune Evasion: Autophagy in Pancreatic Carcinoma

scientific article published on 25 May 2020

Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma

scientific article published in March 2004

Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis

scientific article published on December 2006

Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib.

scientific article

Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

scientific article published on 09 September 2019

Subversion of anticancer immunosurveillance by radiotherapy.

scientific article

Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39.

scientific article published on May 2012

Surface-exposed calreticulin in the interaction between dying cells and phagocytes

scientific article published on October 2010

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

scientific article published on 03 September 2019

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress

scientific article

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy

scientific article

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

scientific article published on 22 February 2011

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

scientific article published on 11 October 2017

Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers

scientific article published on 29 October 2018

Targeting PD-1/PD-L1 interactions for cancer immunotherapy

scientific article published on November 2012

Targeting dendritic cell metabolism in cancer

scientific article published on 01 August 2010

Targeting foxp1 for reinstating anticancer immunosurveillance

scientific article published on 01 September 2014

Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

scientific article published on 10 April 2016

The European Academy of Tumor Immunology: Bridging fields, continents and generations

scientific article

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer

scientific article published on 27 July 2020

The IKK complex contributes to the induction of autophagy

scientific article

The Janus face of dendritic cells in cancer

scientific article published on October 2008

The anticancer immune response: indispensable for therapeutic success?

scientific article published on June 2008

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

scientific article

The complement system is also important in immunogenic cell death

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

scientific article published in May 2008

The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells

scientific article published in August 2009

The dendritic cell-tumor cross-talk in cancer

scientific article published on 21 October 2010

The dilemma of anticancer therapy: tumor-specific versus immune effects

scientific article published in December 2008

The gut microbiota influences anticancer immunosurveillance and general health.

scientific article published on 10 April 2018

The immune contexture in cancer prognosis and treatment

scientific article published on 25 July 2017

The immune system: taming and unleashing cancer

scientific article published on 01 December 2006

The immunogenicity of tumor cell death

scientific article published on January 2009

The impact of the intestinal microbiota in therapeutic responses against cancer

scientific article published on 07 April 2018

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

scientific article published on December 2007

The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

scholarly article by Lisa Derosa et al published 2018 in OncoImmunology

The intimate relationship between gut microbiota and cancer immunotherapy

scholarly article by Arielle Elkrief et al published 19 October 2018 in Gut microbes

The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.

scientific article

The multifaceted granulysin

scientific article published on 01 November 2010

The oncolytic compound LTX-401 targets the Golgi apparatus

scientific article published on 10 November 2017

The oncolytic compound LTX-401 targets the Golgi apparatus.

scientific article published on 2 September 2016

The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization

scientific article

The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

scientific article published on 15 April 2016

The oncolytic peptide LTX-315 triggers immunogenic cell death

scientific article published on 10 March 2016

The oncolytic peptide LTX-315 triggers necrotic cell death

scientific article published on November 2015

The potential of exosomes in immunotherapy

scientific article

The potential of exosomes in immunotherapy of cancer

scientific article

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

scientific article published on 16 March 2016

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

scientific article published on 18 August 2016

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

scientific article published on December 2006

The role of the microbiota in inflammation, carcinogenesis, and cancer therapy

scientific article

The secret ally: immunostimulation by anticancer drugs

scientific article published on 03 February 2012

The ultimate goal of curative anti-cancer therapies: inducing an adaptive anti-tumor immune response

scientific article published on December 2011

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

scientific article

Therapy-induced microenvironmental changes in cancer

scientific article published on 2 March 2016

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells

scientific article published on February 2007

Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions

scientific article

Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab

scientific article

Trial Watch

scientific article

Trial Watch-Immunostimulation with cytokines in cancer therapy

scientific article

Trial Watch-Oncolytic viruses and cancer therapy

scientific article

Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy

scientific article published on 10 March 2016

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

scientific article published on May 2013

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

scientific article published on May 2014

Trial Watch: Adoptive cell transfer for oncological indications

scientific article

Trial Watch: Adoptive cell transfer immunotherapy

scientific article

Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

scientific article published on 11 August 2017

Trial Watch: Anticancer radioimmunotherapy

scientific article published on 3 July 2013

Trial Watch: Chemotherapy with immunogenic cell death inducers.

scientific article published in January 2014

Trial Watch: DNA vaccines for cancer therapy

scientific article published on January 2014

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy

scientific article

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

scientific article

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

scientific article

Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy

scientific article

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

scholarly article by Elena García-Martínez et al published 2018 in OncoImmunology

Trial Watch: Immunostimulatory cytokines

scientific article

Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications

scientific article published on 30 August 2017

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

scientific article published on January 2014

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

scientific article published on 25 July 2016

Trial Watch: Lenalidomide-based immunochemotherapy

scientific article published on 21 October 2013

Trial Watch: Monoclonal antibodies in cancer therapy

scientific article

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

scientific article published on 27 August 2018

Trial Watch: Peptide vaccines in cancer therapy

scientific article published on 4 November 2013

Trial Watch: Peptide-based anticancer vaccines

scientific article

Trial Watch: Radioimmunotherapy for oncological indications

scientific article published in October 2014

Trial Watch: Toll-like receptor agonists for cancer therapy

scientific article published on 10 June 2013

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

scientific article published on 11 October 2018

Trial Watch: Toll-like receptor agonists in oncological indications

scientific article

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

scientific article

Trial Watch:: Oncolytic viruses for cancer therapy

scientific article

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

scientific article published on 03 June 2020

Trial watch: Cardiac glycosides and cancer therapy

scientific article

Trial watch: Chemotherapy with immunogenic cell death inducers.

scientific article published in March 2013

Trial watch: DNA vaccines for cancer therapy

scientific article published on April 2013

Trial watch: DNA-based vaccines for oncological indications

Trial watch: Dendritic cell-based anticancer immunotherapy.

scientific article published on 12 May 2017

Trial watch: Dendritic cell-based anticancer therapy

scientific article

Trial watch: Dendritic cell-based interventions for cancer therapy

scientific article published on 29 July 2013

Trial watch: Dendritic cell-based interventions for cancer therapy

scientific article

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

scientific article

Trial watch: IDO inhibitors in cancer therapy

scientific article

Trial watch: IDO inhibitors in cancer therapy

scientific article published on 14 June 2020

Trial watch: Immune checkpoint blockers for cancer therapy

scientific article published on 31 August 2017

Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

article by Abhishek D. Garg et al published 2017 in OncoImmunology

Trial watch: Immunostimulatory cytokines in cancer therapy

scientific article

Trial watch: Monoclonal antibodies in cancer therapy

article by Erika Vacchelli et al published 1 January 2013 in OncoImmunology

Trial watch: Naked and vectored DNA-based anticancer vaccines

scientific article published on 2 April 2015

Trial watch: Oncolytic viruses for cancer therapy

scientific article published on 16 April 2013

Trial watch: Peptide vaccines in cancer therapy

scientific article published in December 2012

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer

scientific article

Trial watch: STING agonists in cancer therapy

scientific article published on 16 June 2020

Trial watch: TLR3 agonists in cancer therapy

scientific article published on 02 June 2020

Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

scientific article published on January 2015

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

scientific article published on 09 January 2020

Trial watch: dendritic cell vaccination for cancer immunotherapy

scientific article published on 18 July 2019

Trial watch: dietary interventions for cancer therapy

scholarly article by Sarah Lévesque et al published 2019 in OncoImmunology

Trial watch: peptide-based vaccines in anticancer therapy

scientific article published on 06 September 2018

TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves

scholarly article by David P Enot et al published 2018 in OncoImmunology

Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity

scientific article published on 19 January 2010

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

scientific article

Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses

scientific article published on 08 February 2008

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.

scientific article

Tumor lysis with LTX-401 creates anticancer immunity

scientific article published on 13 April 2019

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy

scientific article published on 30 April 2013

Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients

scientific article published on 01 April 2016

Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?

scientific article published on 14 June 2020

Type I interferons in anticancer immunity

scientific article published on June 2015

Unchaining NK cell–mediated anticancer immunosurveillance

Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade

scientific article published on 01 January 2011

Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas

scientific article published on 06 September 2019

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

scientific article

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition

scientific article published on 09 September 2016

Victories and deceptions in tumor immunology: Stimuvax(®)

scientific article published on January 2013

Viral strategies for the evasion of immunogenic cell death

scientific article published on May 2010

Viral subversion of immunogenic cell death

scientific article published on 26 March 2009

Why should we need the gut microbiota to respond to cancer therapies?

scientific article

Witch hunt against tumor cells enhanced by dendritic cells

scientific article published on September 2009

Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1.

scientific article published on 30 March 2016

[A new dendritic cell implicated in antitumoral immunity]

scientific article published on 01 June 2006

[About Ralph M. Steinman and dendritic cells].

scientific article published on 30 November 2011

[Antitumoral immunization during cancer chemotherapy]

scientific article published in June 2012

[Chemokine receptors expression on T cells: contribution to diagnosis of melanoma metastasis dissemination status].

scientific article published on 12 September 2016

[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]

scientific article published on 01 January 2011

[Exosomes and anti-tumour immunotherapy]

scientific article published on 01 August 2003

[IKDC: killer dendritic cells or antigen-presenting NK cells?]

scientific article published on 01 May 2008

[Immunological aspects of anticancer chemotherapy]

scientific article published on 01 October 2008

[Innate defence against tumor cells: the killer cell IKDC]

scientific article published on 01 May 2006

[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]

scientific article published on 01 August 2003

[The role of intestinal microbiota in the response to anti-tumor therapies].

scientific article

[Vaccine strategies against melanoma]

scientific article published on 01 February 2006

acDCs enhance human antigen-specific T-cell responses

scientific article published on 28 June 2011

eIF2α phosphorylation is pathognomonic for immunogenic cell death

scientific article published on 22 January 2018

Paulina is supported by:

About Paulina

Help